Accustem Sciences Inc. (ACUT)
USD 0.24
(0.0%)
USD 0.24
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -3.74 Million USD | -458.66% |
| 2021 | -670.61 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | 833.34 Thousand USD | 185.16% |
| 2023 Q3 | -598.52 Thousand USD | -60.57% |
| 2023 Q2 | -372.75 Thousand USD | -144.73% |
| 2022 Q3 | -899.12 Thousand USD | 16.61% |
| 2022 Q2 | -1.07 Million USD | -100.16% |
| 2022 Q1 | 676.2 Million USD | 100934.38% |
| 2022 FY | - USD | -458.66% |
| 2022 Q4 | -978.53 Thousand USD | -8.83% |
| 2021 Q4 | -670.61 Thousand USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 94.726% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 36.811% |
| SQZ Biotechnologies Company | -64.14 Million USD | 94.159% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 78.432% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 103.984% |
| Mesoblast Limited | -62.38 Million USD | 93.995% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -143.9% |
| Genus plc | 73.7 Million USD | 105.083% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 43.335% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -5.622% |
| Marizyme, Inc. | -34.28 Million USD | 89.072% |
| ContraFect Corporation | -64.99 Million USD | 94.236% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 57.291% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 17.228% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -167.256% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -41.671% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -61.218% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -623.183% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 92.232% |
| EV Biologics, Inc. | -1.26 Million USD | -195.661% |
| Q BioMed Inc. | -617.62 Thousand USD | -506.582% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 204.883% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -492.407% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -63.994% |
| Biomind Labs Inc. | -1.03 Million USD | -262.131% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 137.931% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 47.685% |
| Skye Bioscience, Inc. | -13.54 Million USD | 72.346% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -151.875% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -14885.676% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 3.55% |
| IMV Inc. | -35.52 Million USD | 89.454% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 76.393% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -49.739% |
| GB Sciences, Inc. | -1.41 Million USD | -163.854% |
| Alpha Cognition Inc. | -9.7 Million USD | 61.399% |
| HST Global, Inc. | -5303.00 USD | -70547.162% |
| CSL Limited | 4.78 Billion USD | 100.078% |
| Halberd Corporation | -74.27 Thousand USD | -4943.712% |
| Enzolytics Inc. | -2.12 Million USD | -76.549% |
| Resverlogix Corp. | -11.74 Million USD | 68.094% |
| Affymax, Inc. | -14.29 Million USD | 73.792% |
| SYBLEU INC | -141.57 Thousand USD | -2546.318% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -22.311% |
| argenx SE | -216.02 Million USD | 98.266% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 93.23% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 407.841% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -149.944% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 1088.908% |
| AVAX Technologies, Inc. | -6.11 Million USD | 38.71% |
| Zenith Capital Corp. | -8.6 Million USD | 56.467% |
| Genscript Biotech Corporation | -248.71 Million USD | 98.494% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -21405.189% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -53.136% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -2028.353% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 90.548% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -29.53% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -258.059% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 55817.118% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -114.081% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -95.033% |
| BioStem Technologies, Inc. | -7.55 Million USD | 50.403% |
| ONE Bio Corp. | 13.61 Million USD | 127.521% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -1968.839% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -82.13% |
| Agentix Corp. | -1.37 Million USD | -173.111% |
| LadRx Corporation | 412.28 Thousand USD | 1008.701% |
| Cell Source, Inc. | -4.27 Million USD | 12.314% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -920.208% |
| Regen BioPharma, Inc. | 1.46 Million USD | 355.561% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -299.853% |
| NovAccess Global Inc. | -1.03 Million USD | -262.044% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 142.314% |
| Itoco Inc. | -1.86 Million USD | -100.451% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -886.887% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -235.701% |
| Kadimastem Ltd | -2.62 Million USD | -42.754% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -1466.556% |
| CytoDyn Inc. | -18.02 Million USD | 79.22% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -4640.562% |
| Mobile Lads Corp. | -2.24 Million USD | -67.164% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -30535.53% |
| Qrons Inc. | -40.08 Thousand USD | -9247.12% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -671.379% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 810.312% |
| Rebus Holdings, Inc. | -951 Thousand USD | -293.945% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -252.767% |
| International Stem Cell Corporation | 202 Thousand USD | 1954.663% |
| Bioxytran, Inc. | -3.82 Million USD | 1.93% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -7017.057% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -52.174% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 89.555% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -8225.376% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -36.83% |
| Neutra Corp. | -181.24 Thousand USD | -1967.024% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 81.416% |
| PureTech Health plc | -11.62 Million USD | 67.778% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 81.414% |
| IXICO plc | -707 Thousand USD | -429.904% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 51.25% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 92.251% |
| CSL Limited | 4.73 Billion USD | 100.079% |
| Cellectis S.A. | -92.63 Million USD | 95.956% |